Coventry Shifting Medicare PBM Duties To Medco From CVS Caremark
Executive Summary
Medco credits its pharmacist-based therapeutic research center program with helping to attract new Medicare Part D business from Coventry Health Care
You may also be interested in...
Universal American, CVS/Caremark End Part D Alliance With Membership Split
CVS/Caremark will add Medicare members to its SilverScript stand-alone prescription drug plans in 2009 under an "amicable split" with Part D partner Universal American, announced Feb. 13
Warfarin Dosing Issues Emerge In Early Results From Medco/Mayo Research
Nearly three-fourths of early patient participants in a warfarin research project appear to need non-standard dosing of the drug based on genetic screening, Medco reported during its analyst day presentation Nov. 16
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.